| 000 | 01443 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513044048.0 | ||
| 264 | 0 | _c19950127 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0258-851X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillespie, D | |
| 245 | 0 | 0 |
_aSynergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. _h[electronic resource] |
| 260 |
_bIn vivo (Athens, Greece) _c |
||
| 300 |
_a375-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV _xdrug effects |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPoly I-C _xadverse effects |
| 650 | 0 | 4 |
_aPoly U _xadverse effects |
| 650 | 0 | 4 | _aRNA, Double-Stranded |
| 650 | 0 | 4 |
_aZidovudine _xadverse effects |
| 700 | 1 | _aHubbell, H R | |
| 700 | 1 | _aCarter, W A | |
| 700 | 1 | _aMidgette, P | |
| 700 | 1 | _aElsasser, W | |
| 700 | 1 | _aMullaney, R | |
| 700 | 1 | _aStrayer, D R | |
| 773 | 0 |
_tIn vivo (Athens, Greece) _gvol. 8 _gno. 3 _gp. 375-81 |
|
| 999 |
_c7803083 _d7803083 |
||